HomeCompareRPHCF vs O

RPHCF vs O: Dividend Comparison 2026

RPHCF yields 1.82% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPHCF wins by $43.20M in total portfolio value
10 years
RPHCF
RPHCF
● Live price
1.82%
Share price
$15.20
Annual div
$0.28
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.23M
Annual income
$39,107,153.37
Full RPHCF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — RPHCF vs O

📍 RPHCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHCFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHCF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHCF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHCF
Annual income on $10K today (after 15% tax)
$154.90/yr
After 10yr DRIP, annual income (after tax)
$33,241,080.36/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, RPHCF beats the other by $33,236,743.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHCF + O for your $10,000?

RPHCF: 50%O: 50%
100% O50/50100% RPHCF
Portfolio after 10yr
$21.63M
Annual income
$19,556,128.06/yr
Blended yield
90.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

RPHCF
No analyst data
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHCF buys
0
O buys
0
No recent congressional trades found for RPHCF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHCFO
Forward yield1.82%5.28%
Annual dividend / share$0.28$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%15.1%
Portfolio after 10y$43.23M$34.2K
Annual income after 10y$39,107,153.37$5,102.74
Total dividends collected$42.89M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: RPHCF vs O ($10,000, DRIP)

YearRPHCF PortfolioRPHCF Income/yrO PortfolioO Income/yrGap
1← crossover$11,064$364.47$10,818$608.16+$246.00RPHCF
2$12,593$753.78$11,787$741.68+$806.00RPHCF
3$15,078$1,603.54$12,946$911.00+$2.1KRPHCF
4$19,722$3,588.75$14,345$1,127.94+$5.4KRPHCF
5$29,877$8,774.08$16,056$1,409.05+$13.8KRPHCF
6$56,812$24,844.41$18,171$1,777.83+$38.6KRPHCF
7$149,094$88,305.24$20,820$2,268.21+$128.3KRPHCF
8$592,694$433,162.94$24,188$2,929.90+$568.5KRPHCF
9$3,852,779$3,218,596.09$28,533$3,837.11+$3.82MRPHCF
10$43,229,627$39,107,153.37$34,235$5,102.74+$43.20MRPHCF

RPHCF vs O: Complete Analysis 2026

RPHCFStock

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Full RPHCF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this RPHCF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHCF vs SCHDRPHCF vs JEPIRPHCF vs KORPHCF vs MAINRPHCF vs STAGRPHCF vs ADCRPHCF vs NNNRPHCF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.